Klaus J. Busam focuses on Pathology, Melanoma, Immunohistochemistry, Nevus and Cancer research. Klaus J. Busam usually deals with Pathology and limits it to topics linked to Fluorescence in situ hybridization and Biopsy and Gene rearrangement. His Melanoma research is multidisciplinary, incorporating elements of Cancer, Metastasis, Melanocyte differentiation and Neuroblastoma RAS viral oncogene homolog.
His Immunohistochemistry study incorporates themes from Oral mucosa, Monoclonal antibody, Antigen and MART-1 Antigen. His study in Nevus is interdisciplinary in nature, drawing from both Entrectinib, Kinase and Base sequence. His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, GNA11, Carcinogenesis and Exon.
His primary areas of investigation include Melanoma, Pathology, Dermatology, Immunohistochemistry and Nevus. The subject of his Melanoma research is within the realm of Cancer research. His Cancer research study combines topics in areas such as Mutation and Neuroblastoma RAS viral oncogene homolog.
His studies deal with areas such as Fluorescence in situ hybridization and Melanocytic nevus as well as Pathology. His Dermatology study integrates concerns from other disciplines, such as Lentigo maligna and Spitz nevus. Klaus J. Busam has included themes like Sentinel lymph node and Lesion in his Biopsy study.
Klaus J. Busam spends much of his time researching Melanoma, Pathology, Dermatology, Cancer research and Immunohistochemistry. His research integrates issues of Biopsy and Metastasis in his study of Melanoma. The various areas that Klaus J. Busam examines in his Pathology study include Melanocytoma, Fluorescence in situ hybridization and Head and neck.
His Cancer research research integrates issues from Cancer/testis antigens and Neuroblastoma RAS viral oncogene homolog. His Immunohistochemistry study combines topics from a wide range of disciplines, such as PRAME and Antigen. His Antigen research is multidisciplinary, relying on both Antibody and Monoclonal antibody.
Klaus J. Busam mainly focuses on Melanoma, Pathology, Lentigo maligna, Nevus and Lentigo maligna melanoma. His Melanoma study deals with the bigger picture of Cancer research. His biological study focuses on Immunohistochemistry.
His work in Lentigo maligna addresses subjects such as Dermatology, which are connected to disciplines such as Melanoma in situ, Germline and Dermatoscopy. Klaus J. Busam interconnects Karyotype, SNP array, Chromosome 3 and Loss of heterozygosity in the investigation of issues within Nevus. His Lentigo maligna melanoma research includes themes of Treatment options, Biopsy, Retrospective cohort study and Hair follicle.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Distinct Sets of Genetic Alterations in Melanoma
John A. Curtin;Jane Fridlyand;Toshiro Kageshita;Hetal N. Patel.
The New England Journal of Medicine (2005)
Somatic Activation of KIT in Distinct Subtypes of Melanoma
John A. Curtin;Klaus Busam;Daniel Pinkel;Boris C. Bastian.
Journal of Clinical Oncology (2006)
Mutations in GNA11 in Uveal Melanoma
Catherine D Van Raamsdonk;Klaus G Griewank;Michelle B Crosby;Maria C Garrido.
The New England Journal of Medicine (2010)
KIT as a therapeutic target in metastatic melanoma
Richard D. Carvajal;Cristina R. Antonescu;Jedd D. Wolchok;Paul B. Chapman.
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images.
Gabriele S.V. Campanella;Gabriele S.V. Campanella;Matthew G. Hanna;Luke Geneslaw;Allen Miraflor.
Nature Medicine (2019)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa.
Modern Pathology (2018)
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.
K.J. Busam;P. Capodieci;R. Motzer;T. Kiehn.
British Journal of Dermatology (2001)
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
Thomas Wiesner;Jie He;Roman Yelensky;Rosaura Esteve-Puig.
Nature Communications (2014)
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.
Nora Pencheva;Hien Tran;Colin Buss;Doowon Huh.
Analysis of BRAF and N-RAS Mutations in Metastatic Melanoma Tissues
Alexis Gorden;Iman Osman;Weiming Gai;Dan He.
Cancer Research (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: